Here's Why Teladoc Health Stock Fell 16% in February
Shares of Teladoc Health (NYSE: TDOC) fell 16.2% in February, according to data provided by S&P Global Market Intelligence. During the month, the company dazzled investors with impressive full-year 2020 results. But its guidance fell short of expectations, leading to the majority of the stock's decline.
For full-year 2020, Teladoc's revenue nearly doubled, up 98% to nearly $1.1 billion. Visits were up even more, with a 156% increase over 2019. It certainly was a stellar year, as the pandemic pushed the adoption of the remote healthcare services that the company provides.
Image source: Getty Images.
Source Fool.com
